Viewing Study NCT06102395


Ignite Creation Date: 2025-12-24 @ 1:39 PM
Ignite Modification Date: 2025-12-27 @ 9:14 PM
Study NCT ID: NCT06102395
Status: RECRUITING
Last Update Posted: 2023-10-30
First Post: 2023-04-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC
Sponsor: Beijing Tongren Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module